Table 3 The subgroup analysis of meta-analysis on implant stability at 4 weeks after insertion
Group | Number of studies | SMDa (MDb) | 95% CIc | Heterogeneity | |
|---|---|---|---|---|---|
Pheterogeneity | I2 (%) | ||||
Type of platelet concentrates | |||||
PRFd | 4 | 0.80 | (0.52–1.08) | 0.92 | 0 |
CGFe | 2 | 0.84 | (0.32–1.35) | 0.23 | 32 |
PRPf | 2 | 0.28 | (− 0.12 to 0.69) | 0.69 | 0 |
Method of application | |||||
Dipping the implant in the liquid before insertion | 5 | 0.65 | (0.40–0.91) | 0.18 | 36 |
Only placed in the implant sites | 3 | 0.70 | (0.34–1.06) | 0.79 | 0 |
Study design | |||||
RCTg | 5 | 0.82 | (0.55–1.09) | 0.69 | 0 |
CCTh | 3 | 0.43 | (0.09–0.77) | 0.47 | 0 |